Rhythm Pharmaceuticals, Inc. (BMV:RYTM)

Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	127,006	71,688	45,928	32,007	10,285	26,151
Market Cap Growth	74.08%	56.09%	43.49%	211.21%	-60.67%	37.47%
Enterprise Value	124,166	70,779	40,893	25,264	3,608	22,199
Last Close Price	1866.76	958.00	553.07	550.00	185.04	610.00
PS Ratio	39.72	26.44	35.09	69.42	159.06	-
PB Ratio	23.42	20.91	16.00	6.21	1.77	7.89
P/TBV Ratio	48.33	221.17	16.69	6.40	1.80	7.89
EV/Sales Ratio	39.15	26.10	31.24	54.79	55.81	-
Debt / Equity Ratio	0.38	0.69	0.63	0.29	0.01	0.02
Asset Turnover	0.40	0.36	0.22	0.07	0.01	-
Inventory Turnover	1.03	0.98	1.61	1.41	-	-
Quick Ratio	4.31	2.94	5.27	8.53	6.81	9.60
Current Ratio	4.75	3.24	5.58	8.90	7.10	10.10
Return on Equity (ROE)	-85.79%	-155.91%	-85.10%	-66.05%	-30.89%	-59.88%
Return on Assets (ROA)	-26.74%	-45.77%	-32.22%	-31.45%	-41.15%	-34.45%
Return on Capital (ROIC)	-34.49%	-59.75%	-37.22%	-35.62%	-46.59%	-37.59%
Return on Capital Employed (ROCE)	-46.30%	-95.90%	-66.40%	-52.30%	-59.40%	-80.80%
Earnings Yield	-2.86%	-7.58%	-6.80%	-11.04%	-13.88%	-10.20%
FCF Yield	-	-3.31%	-5.01%	-10.59%	-29.19%	-9.30%
Buyback Yield / Dilution	-5.39%	-5.76%	-10.65%	-5.08%	-12.40%	-21.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.